PMID- 35935922
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220809
IS  - 1078-4497 (Print)
IS  - 1945-337X (Electronic)
IS  - 1078-4497 (Linking)
VI  - 39
IP  - 5
DP  - 2022 May
TI  - Natriuretic Peptide Screening for Primary Prevention or Early Detection of Heart 
      Failure: A Pharmacist-Driven Team-Based Approach.
PG  - 212-217
LID - 10.12788/fp.0255 [doi]
AB  - BACKGROUND: Emerging data indicates that natriuretic peptide biomarker-based 
      screening and early intervention could prevent left ventricular dysfunction or 
      new-onset heart failure (HF). The 2017 update of the American College of 
      Cardiology/ American Heart Association/Heart Failure Society of America guideline 
      for managing HF provides a IIa recommendation for natriuretic peptide biomarker 
      screening followed by a team-based approach for preventing HF. OBSERVATIONS: 
      Clinical pharmacists worked collaboratively with a cardiology specialist and 
      primary care practitioners to establish a protocol to identify patients at risk 
      for HF. Patients with hypertension and/or type 2 diabetes mellitus (T2DM) and 
      without a history of HF with N-terminal pro-B-type natriuretic peptide > 125 
      pg/mL received follow-up from clinical pharmacists, including initiation and/or 
      adjustment of reninangiotensin system inhibitors, discussion of echocardiogram, 
      and comprehensive disease state management of hypertension, T2DM, atherosclerotic 
      cardiovascular disease risk reduction, oral nonsteroidal anti-inflammatory drug 
      reduction, and tobacco cessation. CONCLUSIONS: By using natriuretic peptide 
      screening, clinical pharmacists were able to identify patients with hypertension 
      and/or T2DM who were at higher risk for HF and provide comprehensive medication 
      management.
CI  - Copyright (c) 2022 Frontline Medical Communications Inc., Parsippany, NJ, USA.
FAU - Martin, Meghan
AU  - Martin M
AD  - Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia.
FAU - Peterson, Daisy
AU  - Peterson D
AD  - Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin.
FAU - Yentz, Casie
AU  - Yentz C
AD  - Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin.
FAU - Charlson, Kristen
AU  - Charlson K
AD  - Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin.
LA  - eng
PT  - Journal Article
DEP - 20220512
PL  - United States
TA  - Fed Pract
JT  - Federal practitioner : for the health care professionals of the VA, DoD, and PHS
JID - 9500574
PMC - PMC9351738
COIS- Author disclosures The authors report no actual or potential conflicts of 
      interest or outside sources of finding with regard to this article.
EDAT- 2022/08/09 06:00
MHDA- 2022/08/09 06:01
PMCR- 2022/05/01
CRDT- 2022/08/08 03:41
PHST- 2022/08/08 03:41 [entrez]
PHST- 2022/08/09 06:00 [pubmed]
PHST- 2022/08/09 06:01 [medline]
PHST- 2022/05/01 00:00 [pmc-release]
AID - fp-39-05-212 [pii]
AID - 10.12788/fp.0255 [doi]
PST - ppublish
SO  - Fed Pract. 2022 May;39(5):212-217. doi: 10.12788/fp.0255. Epub 2022 May 12.